$37.63
+0.16(0.43%)
Mkt Cap $3.3B
$11.99
$46.63
52-Week Range
At A Glance
1
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.
2
Revenue is primarily driven by Product (78.1%) and Service (21.9%).
3
Most recently: of this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise su (2026-03-05).
$3.3B
Market Cap
$160M
Revenue
-$70M
Net Income
Employees170
Fundamentals
How The Business Makes Money
Revenue by Segment
Product78.1%($297M)
Service21.9%($83M)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0001819576
ISINUS53635D2027
CUSIP53635D202
Phone919 328 4400
Address419 Davis Drive, Morrisville, NC, 27560, US
SEC EDGAR